Clinical Trial Update: Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID) [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial update for VGA039 in healthy volunteers and patients with Von Willebrand disease, spanning Phase 1/2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Von Willebrand Disease

Drugs mentioned

• VGA039

Snippet

Sponsor: Vega Therapeutics, Inc | Conditions: Von Willebrand Diseases | Phase 1, Phase 2 | Status: RECRUITING